GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » Price-to-Tangible-Book
中文

Cybin (CYBN) Price-to-Tangible-Book : 4.73 (As of Apr. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Price-to-Tangible-Book?

As of today (2024-04-24), Cybin's share price is $0.355. Cybin's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.08. Hence, Cybin's Price to Tangible Book Ratio of today is 4.73.

The historical rank and industry rank for Cybin's Price-to-Tangible-Book or its related term are showing as below:

CYBN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.01   Med: 5.25   Max: 10.42
Current: 5.07

During the past 4 years, Cybin's highest Price to Tangible Book Ratio was 10.42. The lowest was 3.01. And the median was 5.25.

CYBN's Price-to-Tangible-Book is ranked worse than
71.67% of 1218 companies
in the Biotechnology industry
Industry Median: 2.69 vs CYBN: 5.07

A closely related ratio is called PB Ratio. As of today, Cybin's share price is $0.355. Cybin's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.22. Hence, Cybin's P/B Ratio of today is 1.60.


Cybin Price-to-Tangible-Book Historical Data

The historical data trend for Cybin's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Price-to-Tangible-Book Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
- 3.39 3.35 5.75

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 5.75 10.50 10.42 5.47

Competitive Comparison of Cybin's Price-to-Tangible-Book

For the Biotechnology subindustry, Cybin's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cybin's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cybin's Price-to-Tangible-Book falls into.



Cybin Price-to-Tangible-Book Calculation

Cybin's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.355/0.075
=4.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Cybin Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cybin's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin (CYBN) Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.